Real-time enrollment status for this severe asthma clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 6:37 AM UTC
| NCT Number | NCT06023589 |
| Recruiting Status | Recruiting |
| Condition | Severe Asthma |
| Phase | PHASE3 |
| Target Enrollment | 231 participants |
| Active Locations | 30 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 13, 2026 (5 days ago) |
As of October 18, 2026: Clinical trial NCT06023589 is currently recruiting participants. This phase3 study for severe asthma is actively seeking new participants at 30 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06023589 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06023589 was last updated 5 days ago (October 13, 2026). HelloStudys verifies this status automatically.